(Q35113820)

6 August 2017

1 reference

title

The emerging role of irinotecan (CPT-11) in the treatment of malignant glioma in brain tumors (English)

1 reference

6 August 2017

1 reference

1 reference

1

Henry S Friedman

1 reference

6 August 2017

3

Peter J Houghton

1 reference

6 August 2017

Stephen T Keir

2

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

97

1 reference

6 August 2017

issue

9 Suppl

1 reference

6 August 2017

page(s)

2359-2362

1 reference

Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against pediatric and adult central nervous system tumor xenografts.

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11305

7 January 2021

Irinotecan therapy in adults with recurrent or progressive malignant glioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11305

7 January 2021

Enhancement of irinotecan (CPT-11) activity against central nervous system tumor xenografts by alkylating agents

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11305

7 January 2021

Schedule-dependent activity of irinotecan plus BCNU against malignant glioma xenografts.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11305

7 January 2021

Identifiers

DOI

10.1002/CNCR.11305

1 reference

6 August 2017

1 reference